For any given medical problem, it seems, there’s a research team trying to use stem cells to find a solution…But in one study expected to launch later this year, scientists hope to use stem cells in a new, highly controversial way — to reverse death.
The idea of the trial, run by Philadelphia-based Bioquark, is to inject stem cells into the spinal cords of people who have been declared clinically brain-dead. The subjects will also receive an injected protein blend, electrical nerve stimulation, and laser therapy directed at the brain.
The ultimate goal: to grow new neurons and spur them to connect to each other, and thereby bring the brain back to life.
…
This isn’t the first start for the trial. The study launched in Rudrapur, India, in April 2016 — but it never enrolled any patients. Regulators shut the study down in November 2016 because…India’s Drug Controller General hadn’t cleared it.
…
Now, the company is in the final stages of finding a new location to host trials. The company will announce a trial in Latin America in coming months….
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Resurrected: A controversial trial to bring the dead back to life plans a restart
